“…In that study, there was a significant difference in the ratio of lipid-rich plaque among 3 of the MetS components groups: MetS components 0-2, MetS components 3, and MetS components 4-5. 15 It was concluded that MetS was an independent predictor of lipid-rich plaque, contributing to an increased risk of cardiovascular disease. However, an observational study can not evaluate the impact of MetS and its components on coronary PV change in ACS patients under statin intervention.…”